These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2872800)

  • 1. Role of selective alpha 1 blockers in the therapy of hypertension.
    Kaplan NM
    Am J Med; 1986 May; 80(5B):100-4. PubMed ID: 2872800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terazosin: a new antihypertensive agent with favorable effects on lipids.
    Luther RR
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive therapy: taking lipids into consideration.
    Grimm RH
    Am Heart J; 1991 Sep; 122(3 Pt 2):910-8. PubMed ID: 1678922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties.
    Leren P
    Am J Med; 1987 Jan; 82(1A):31-5. PubMed ID: 2879461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
    Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating hypertension and cardiovascular risk: are there trade-offs?
    Grimm RH
    Am Heart J; 1990 Mar; 119(3 Pt 2):729-32; discussion 732. PubMed ID: 1968699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
    Kincaid-Smith P
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; de Courten M; Ferrari P; Böhlen L
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of non-beta-blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension?
    Ames RP
    Am Heart J; 1987 Oct; 114(4 Pt 2):998-1006. PubMed ID: 2889346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.
    Ames RP
    Drugs; 1986 Oct; 32(4):335-57. PubMed ID: 2877846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension.
    Luther RR; Glassman HN; Estep CB; Schmitz PJ; Horton JK; Jordan DC
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):237S-240S. PubMed ID: 2901267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The place of alpha blockers in the antihypertensive armamentarium.
    Carruthers SG
    J Clin Pharmacol; 1993 Mar; 33(3):260-3. PubMed ID: 8096522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism.
    Nash DT
    Clin Cardiol; 1990 Nov; 13(11):764-72. PubMed ID: 1980236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary heart disease and treatment of hypertension. Some Oslo Study data.
    Leren P; Helgeland A
    Am J Med; 1986 Feb; 80(2A):3-6. PubMed ID: 2868657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective alpha-1 inhibitors: first- or second-line antihypertensive agents?
    Lund-Johansen P; Hjermann I; Iversen BM; Thaulow E
    Cardiology; 1993; 83(3):150-9. PubMed ID: 7904230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of alpha- versus beta-blockers on hypertensive target organ damage: results of a double-blind, randomized, controlled clinical trial.
    Schmieder RE; Langenfeld MR; Gatzka CD; Weidinger G; Schobel HP
    Am J Hypertens; 1997 Sep; 10(9 Pt 1):985-91. PubMed ID: 9324103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential benefit of combination therapy with diuretics and beta blockers having intrinsic sympathomimetic activity.
    Weinberger MH
    Eur Heart J; 1990 Jun; 11(6):560-5. PubMed ID: 1972064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.